VACCINATION AGAINST ROTAVIRUS INFECTION AS A CONTRIBUTION TO CHILDREN'S HEALTH
https://doi.org/10.22627/2072-8107-2017-16-4-46-48
Abstract
The analysis of the antenatal period of ontogeny in 1267 children of city Achinsk found risk factors that contributed to the development of pathology in the early postnatal period in 43.7% of newborns, the emergence of an acute infectious (32.5%) and somatic (19.2%) pathology requiring hospitalization in 6.9% of cases. The pilot project on immunization against rotavirus infection of newborns in city Achinsk has reduced the number of hospitalizations for intestinal infections in this group by 39.1%.
About the Authors
A. G. Yuzhakova
Krasnoyarsk State Medical University named after professor V.F. Voino-Yasenetsky, Krasnoyarsk
Russian Federation
post-graduate student of the Department of Pediatrics Infectious Diseases
Russian Federation
post-graduate student of the Department of Pediatrics Infectious Diseases
G. P. Martynova
Krasnoyarsk State Medical University named after professor V.F. Voino-Yasenetsky, Krasnoyarsk
Russian Federation
Russian Federation
MD, Professor, Head of the Department of Pediatric Infectious Diseases
+7(391) 224-32-95
References
1. Lim S.S., Allen K., Bhutta Z.A., Dandona L. et al. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015. Lancet. 2016; 388: 1813—1850.
2. Федеральная служба государственной статистики: Здравоохранение в России, 2015 г. [Federal State Statistics Service: Health in Russia, 2015. (In Russ).]
3. Баранов А.А., Намазова-Баранова Л.С. Федеральные клинические рекомендации по вакцинопрофилактике ротавирусной инфекции у детей. Министерство здравоохранения Российской Федерации, Союз педиатров России, 2015: 7. [Baranov A.A., Namazova-Baranova L.S. Federal clinical guidelines for the vaccine prophylaxis of rotavirus infection in children. Ministry of Health of the Russian Federation, the Union of Pediatricians of Russia. 2015: 7. (In Russ).]
4. Брико Н.И., Горелов А.В. Ротавирусная инфекция: современный взгляд на проблему. Медицинский вестник. 2013; 14—15: 663—664. [Briko N.I., Gorelov A.V. Rotavirus: contemporary view on the problem. Medical Bulletin. 2013; 14—15: 663—664. (In Russ).]
5. Подколзин А.Т. Веселова О.А., Яковенко М.Л., Коновалова Т.А., и др. Анализ структуры летальных исходов у детей младшего возраста при острых кишечных инфекциях. Инфекционные болезни. 2013; 2: 38—44. [Podkolzin A.T., Veselova O.A., Yakovenko M.L., Konovalova T.A. Analysis of the structure of deaths among young children at acute intestinal infections. Infectious Diseases. 2013; 2: 38—44. (In Russ)]
6. Yu J., Jung K., Kan H. Comparative Study between Febrile Convulsions and Benign Convulsions Associated with Viral Gastroenteritis. Journal of Epilepsy Research. 2011; 1(1):19—26.
7. Послова, Л.Ю., Ковалишена О.В., Чубукова О.А., Сергеева А.В. Клинико-эпидемиологическая характеристика ротавирусной инфекции в детском многопрофильном стационаре. Медицинский альманах. 2015; 40(5): 60—65. [Poslova L.Yu., Kovalishena O.V., Chubukona O.A., Sergeeva A.V. Clinical and epidemiological characteristics of rotaviral infection in children multipurpose day-and-night clinic. Meditsinskiy al'manakh=Medical almanac. 2015; 40(5): 60—65. (In Russ)]
8. Zlamy M., Kofler S., Orth D., Wurzner R. et al. The impact of Rotavirus mass vaccination on hospitalization rates, nosocomial Rotavirus gastroenteritis and secondary blood stream infections. BMC Infectious Diseases. 2013; 13:112.
9. WHO Ending Preventable Child Deaths from Pneumonia and Diarrhoea by 2025. The integrated Global Action Plan for Pneumonia and Diarrhoea (GAPPD) / WHO, 2013. http://apps.who.int/ iris/bitstream/10665/79200/1/9789241505239_eng.pdf
10. WHO/IVB Database, as of 11 January 2016 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization. http://www.who.int/immunization/ monitoring_surveillance/VaccineIntroStatus.pptx
11. Dennehy P.H., Vesikari T., Matson D.O., Itzler R.F. et al. Efficacy of the pentavalent rotavirus vaccine, RotaTeq® (RV5), between doses of a 3-dose series and with less than 3 doses (incomplete regimen). Hum Vaccin. 2011; 7(5):563—568.
12. Wang F.T., Mast T.C., Glass R.J., Seeger J.D. Effectiveness of an incomplete RotaTeq (RV5) vaccination regimen in preventing rotavirus gastroenteritis in the United States. The Pediatric Infectious Disease Journal. 2012; 32(3).
Review
For citations:
Yuzhakova A.G., Martynova G.P. VACCINATION AGAINST ROTAVIRUS INFECTION AS A CONTRIBUTION TO CHILDREN'S HEALTH. CHILDREN INFECTIONS. 2017;16(4):46-48. (In Russ.) https://doi.org/10.22627/2072-8107-2017-16-4-46-48
Views:
879
Email this article 